// App-Quantinova.ai

TCT-361 : Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Researchers

Presenter

  • Giulio Stefanini

Principal Investigators

  • Lorenz Raber

  • Michael Magro

  • Stephan Windecker

  • Bindu Kalesan

  • Masanori Taniwaki

  • cihan simsek

  • Peter Wenaweser

  • Ron van Domburg

  • Bernhard Meier

  • Peter Juni

  • Patrick Serruys

Medical Centers

  • University of Zurich Institute of Social and Preventive Medicine, Zurich, Switzerland

  • IBCSG and University Hospital, Berne, Switzerland

  • Thoraxcenter, Erasmus MC, Rotterdam, Netherlands

Locations

  • Switzerland

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Paclitaxel

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved